neurontin

Generic: gabapentin

Labeler: parke-davis div of pfizer inc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name neurontin
Generic Name gabapentin
Labeler parke-davis div of pfizer inc
Dosage Form SOLUTION
Routes
ORAL
Active Ingredients

gabapentin 250 mg/5mL

Manufacturer
Parke-Davis Div of Pfizer Inc

Identifiers & Regulatory

Product NDC 0071-2012
Product ID 0071-2012_07bff022-5505-4611-a9a0-ce5255c339ad
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA021129
Marketing Start 2000-03-02
Marketing End 2027-01-31

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00712012
Hyphenated Format 0071-2012

Supplemental Identifiers

RxCUI
105028 105029 105030 261280 261281 283523 310430 310431 310432 310433 310434 351973
UPC
0300710513242
UNII
6CW7F3G59X
NUI
N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name neurontin (source: ndc)
Generic Name gabapentin (source: ndc)
Application Number NDA021129 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/5mL
source: ndc
Packaging
  • 1 BOTTLE, PLASTIC in 1 CARTON (0071-2012-47) / 470 mL in 1 BOTTLE, PLASTIC
source: ndc

Packages (1)

0071-2012-47 1 BOTTLE, PLASTIC in 1 CARTON (0071-2012-47) / 470 mL in 1 BOTTLE, PLASTIC

Ingredients (1)

gabapentin (250 mg/5mL)

Linked Drug Pages (1)

Neurontin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "07bff022-5505-4611-a9a0-ce5255c339ad", "openfda": {"nui": ["N0000008486"], "upc": ["0300710513242"], "unii": ["6CW7F3G59X"], "rxcui": ["105028", "105029", "105030", "261280", "261281", "283523", "310430", "310431", "310432", "310433", "310434", "351973"], "spl_set_id": ["ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Parke-Davis Div of Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (0071-2012-47)  / 470 mL in 1 BOTTLE, PLASTIC", "package_ndc": "0071-2012-47", "marketing_end_date": "20270131", "marketing_start_date": "20220712"}], "brand_name": "Neurontin", "product_id": "0071-2012_07bff022-5505-4611-a9a0-ce5255c339ad", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0071-2012", "generic_name": "gabapentin", "labeler_name": "Parke-Davis Div of Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Neurontin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "250 mg/5mL"}], "application_number": "NDA021129", "marketing_category": "NDA", "marketing_end_date": "20270131", "marketing_start_date": "20000302"}